1 Stage 3 Meaningful Use FINAL Rule Cathy Costello, JD Director of CliniSyncPLUS Services And Scott Mash, MSLIT, CPHIMS, FHIMSS Director of Consulting Operations & HIE Outreach (on all master slides)
2 Conflicts of Interest Cathy Costello and Scott Mash have no actual or potential conflict of interest in relation to this presentation.
3 Learning Objectives 1. Review the new and modified objectives and requirements for Stage 3 of Meaningful Use. 2. Discuss potential challenges providers may face in achieving Stage 3 and the planning necessary to overcome those challenges. 3. Discuss potential strategies for meeting the Stage 3 care coordination related objectives. 4. Describe the patient engagement requirements focusing on the potential provided by the new API requirement. 5. Review the variance in Stage 3 Meaningful Use and CQM reporting from 2017 to 2018.
4 Before we begin... Stop & take a breath!
5 MU Rules Released The policy rule released on Tuesday, October 6, 2015 covers: 2015 and 2016 MU reporting 2017 transitional reporting for Stage Stage 3 The certification criteria rule was released simultaneously; criteria cover the Stage 3 upgrades. This version is referred to as 2015 Edition CEHRT.
6 Timeline for MU Rules The MU measures for and Stage 3 are final effective 60 days after publication. The policy rules for MU and Stage 3-RIN 0938-AS58 ( ) and RIN 0938-AS26 (Stage 3) have been combined and were formally published in the Federal Register October 16, The policy rule will become final effective December 15, The related rule, certification criteria for Stage 3, was released as a separate rule, RIN 0991-AB93. It will not become effective until 90 days after publication, January 14, Comments are still being sought for specific provisions for Stage 3 related to alternative payment programs.
7 MU Reporting Timeline for Stage 3 Blended Stage 1 & Stage Blended Stage 1 & Stage 2 OR Stage One unified set of reporting measures with exclusions & alternate measures 1 year reporting A blended measures with fewer exclusions; 1 year reporting OR B. Stage 3 measures; 90 day reporting Stage Stage 3 measures 1 year reporting CQM measures electronically reported
8 How MU Will Change in 2016 Blends Stage 1 & 2 into one set of measures; some exclusions & alternate measures 9 required EP measures + 2 public health/registry reporting measures. 8 required EH measures + 3 public health/registry reporting measures. All reporting will be 1 year CQM reporting: EPs: 9 CQMs across at least 3 domains; either attestation or electronic; 365 day reporting period EHs (Subsection(d) Hospitals): 4 CQMs submitted electronically (ecqms) for either Q3 or Q4 through QualityNet portal CAHs: 16 CQMs across at least 3 domains either attestation or electronic; 365 day reporting period
9 How MU Will Change in 2017 A. If attesting to blended Stage 1 & 2: Same measures as 2016; some exclusions different Reporting will be 1 year CQM reporting: EPs: 9 CQMs across at least 3 domains; either attestation or electronic; 365 day reporting period EHs (Subsection(d) Hospitals): 16 CQMs across at least 3 domains either attestation or electronic; 365 day reporting period CAHs: 16 CQMs across at least 3 domains either attestation or electronic; 365 day reporting period
10 How MU Will Change in 2017 (cont) B. If attesting to Stage 3: 7 EP measures + 2 public health/registry reporting measures 7 EH measures + 4 public health/registry reporting measures Reporting will be 90 days Attestation can t occur until January 2018 CQM reporting must be for 365 days even if attesting to MU CQMs: EPs: 9 CQMs across at least 3 domains; either attestation or electronic; 365 day reporting period EHs (Subsection(d) Hospitals): 16 CQMs across at least 3 domains either attestation or electronic; 365 day reporting period CAHs: 16 CQMs across at least 3 domains either attestation or electronic; 365 day reporting period
11 Stage Measures Stage 3 Measures Protect Electronic Health Information 1 Protect Electronic Health Information 2 Clinical Decision Support 2 Electronic Prescribing (erx) 3 Computerized Provider Order Entry (CPOE) 4 Electronic Prescribing (erx) 4 3 Clinical Decision Support Computerized Provider Order Entry (CPOE) 5 Health Information Exchange 5 Patient Electronic Access 6 Patient-Specific Education 6 Coordination of Care through Patient Engagement 7 Medication Reconciliation 7 Health Information Exchange 8 Patient Electronic Access 8 9 EP Secure Messaging 10 Public Health Reporting Public Health & Clinical Data Registry Reporting
12 Meeting MU Stage 3 by Year # 1 Measure or Attestation Information Reporting Period 90 days 1 year Certification Criteria for CEHRT Protect Electronic Health Information Any combination of 2014, 2015 Edition CEHRT Review in calendar year prior to attestation 2 Electronic Prescribing (erx) >60% >60% 2015 Edition CEHRT Review in calendar year 3 Clinical Decision Support 5 across 4 domains 5 across 4 domains 4 CPOE 5 Patient Electronic Access 6 Coordination of Care through Patient Engagement Med orders: >60% Lab orders: >60% Imaging orders: >60% Access: >80% unique patients to portal & API Education: >35% unique pts. 1) VDT/API: 5% 2) Secure message sent: 5% 3) Health data incorporated: 5% Med orders: >60% Lab orders: >60% Imaging orders: >60% Access: >80% unique patients to portal & API Education: >35% unique pts. 1) VDT/API: 10% 2) Secure message sent: 25% 3) Health data incorporated: 5%
13 Meeting MU Stage 3 by Year (cont) # Measure or Attestation Information 7 Health Information Exchange 8 Public Health & Clinical Data Registry Reporting CQM Reporting ) Electronic summary of care sent: 50% 2) Incorporation of summary of care into record: 40% 3) Perform clinical information reconciliation for meds, med allergies and current problems for new patients: 80% EPs: 2 (syndromic no longer available except for urgent care) EHs: Annual Update; attestation or ecqm reporting; 365 day reporting period 1) Electronic summary of care sent: 50% 2) Incorporation of summary of care into record: 40% 3) Perform clinical information reconciliation for meds, med allergies and current problems for new patients: 80% EPs: 2 (syndromic no longer available except for urgent care) EHs: Annual Update; ecqm reporting; 365 day reporting period
14 Protect Patient Health Information OBJECTIVE 1: Protect electronic health information created or maintained by the CEHRT through the implementation of appropriate technical capabilities. MEASURE: Conduct or review a security risk analysis in accordance with the requirements in 45 CFR (a)(1), including addressing the security (to include encryption) of ephi created or maintained by CEHRT in accordance with requirements and implement security updates as necessary and correct identified security deficiencies as part of the risk management process. Rule references Office of Civil Rights (OCR) guidance on conducting security risk analysis in accordance with HIPAA Security Rule (dated July 14, 2010) ( ) and the ONC/OCR Security Risk Assessment (SRA) Tool: (
15 Protect Patient Health Information More clarification on timing and content of security reviews: Review needs to incorporate anticipated changes in the CEHRT system: We note that a security risk analysis is not a discrete item in time, but a comprehensive analysis covering the full period of time for which it is applicable..the analysis and review are not merely episodic but should cover a span of the entire year, including a review planning for future system changes within the year or a review of prior system changes within the year. If attestation period is 90 days, the period of time for security review is clarified: If the EHR reporting period is 90 days, it must be completed in the same calendar year. This may occur either before or during the EHR reporting period; or, it occurs after the EHR reporting period, it must occur before the provider attests or before the end of the calendar year, whichever date comes first. Security risk analysis tool ( is applicable to all organizations regardless of size.
16 EP Electronic Prescribing (erx) EP OBJECTIVE 2: Generate and transmit permissible prescriptions electronically (erx). EP MEASURE: > 60% of all permissible prescriptions are: Queried for drug formulary Transmitted electronically EP EXCLUSION: EP who writes < 100 prescriptions during the reporting period.
17 EH Electronic Prescribing (erx) EH OBJECTIVE 2: Hospital discharge medications for permissible prescriptions (erx) are queried for drug formulary and transmitted electronically. EH MEASURE: > 25% of all hospital discharge medication orders for permissible prescriptions (for new and changed prescriptions) are: Queried for a drug formulary Transmitted electronically EH EXCLUSION: No internal pharmacy that accepts erx and no pharmacy within 10 miles accepts erx.
18 Issues Raised about Electronic Prescribing of Controlled Substances (EPCS) Role of controlled substances E-prescribing unclear in Stage 3 The term controlled substances used in the proposed rule is replaced by the term permissible prescriptions. There is a significant discussion on the use of E-prescribing of Controlled Substances (EPCS) in the rule. The status changes from permitted to include them in to being required to include them if it is permissible under state law (such as Ohio): We are modifying the denominator (for erx) to remove this language (i.e., controlled substances). Again, we note this is only a change in wording and does not change the substance of our current policy that providers have the option, but are not required, to include prescriptions for controlled substances in the measure for Stage 3. For EHR Incentive Programs in , we note that inclusion of controlled substances under permissible prescriptions is optional For Stage 3, while we intended to maintain this option, based on public comments and the progress of states toward acceptance of EPCS we are modifying this policy that the inclusion of controlled substances should be required where it is feasible to electronically prescribe the drug and where allowable by law.
19 Issues Raised about Electronic Prescribing of Controlled Substances (EPCS) cont Role of controlled substances e-prescribing unclear in Stage 3 (cont): Therefore, we are changing the measure for this objective to remove the language regarding controlled substances. Instead, we are adopting that under permissible prescriptions for the Stage 3 objective providers must may include electronic prescriptions of controlled substances in the measure where creation of an electronic prescription for the medication is feasible using CEHRT and where allowed by law for the duration of the EHR reporting period. There are no corresponding certification criteria for controlled substances e-prescribing in the CMS 2015 Ed. rule. For more information on requirements for EPCS and available pharmacies, see:
20 Ohio Electronic Prescribing of Controlled Substances (EPCS)
21 Clinical Decision Support OBJECTIVE 3: Implement clinical decision support (CDS) interventions focused on improving performance on high-priority health conditions. MEASURE 1: Implement 5 clinical decision support interventions related to 4 or more CQMs at a relevant point in patient care for the entire EHR reporting period. Absent 4 CQMS, CDS must be related to high-priority health conditions. MEASURE 2: Drug/Drug and Drug/Allergy interaction checking functionality enabled. EP EXCLUSION FOR DRUG/DRUG & DRUG/ALLERGY: EP who writes < 100 medication orders during the reporting period.
22 Computerized Provider Order Entry OBJECTIVE 4: Use computerized provider order entry for medication, laboratory, and radiology orders directly entered by any licensed healthcare professional that can enter orders per state, local & professional guidelines. MEASURE 1: > 60% of medication orders created by EP or by authorized providers of the EH s inpatient or emergency department (POS 21 or 23) during the EHR reporting period are recorded using CPOE. MEASURE 2: > 60% of laboratory orders created by EP or authorized providers of hospital s inpatient or ED recorded using CPOE. MEASURE 3: > 60% of diagnostic imaging orders created by EP or authorized providers of hospital s inpatient or ED are recorded using CPOE. EP EXCLUSION: EP who writes < 100 med orders, < 100 lab orders or < 100 diagnostic imaging orders during the reporting period is excluded from that particular measure.
23 CPOE Notes on Who May Enter CMS defers to the provider s discretion to determine the appropriateness of the credentialing to ensure that any staff entering orders have the clinical training and knowledge required to enter orders for CPOE. We reiterate that CMS does not require any specific or general certification and note that credentialing may take many forms including, but not limited to, the appropriate degree from a health training and education program from which the medical staff matriculated. Determination of individuals who should be permitted to do CPOE based on: Organizational workflows Appropriate credentialing of the staff member by an organization other than the employing organization Analysis of duties performed by the staff member Compliance with all applicable federal, state and local laws and professional guidelines
24 CPOE Expanded for Radiology Orders Radiology CPOE now expanded to diagnostic imaging to include: Ultrasounds CT-scans MRIs and all other diagnostic imaging
25 Patient Electronic Access OBJECTIVE 5: Provide patients (or patient-authorized representative) with timely electronic access to their health information and patient-specific education. MEASURE 1 (Access): > 80% of unique patients seen by EP or discharged from the EH: Provided timely access to view, download, and transmit health information; and Provider ensures the patient s PHI is available to access using any application of their choice configured to meet the technical specs of the API in the provider s CEHRT MEASURE 2 (Patient Education): For >35% of unique patients seen by EP or discharged from the EH: EP or EH must use clinically relevant information from CEHRT to identify patientspecific educational resources and provide electronic access to those materials >35% of unique patients seen by EP or discharged from EH EXCLUSIONS: EP: EP has no office visits during the reporting period EP/EH: EP conducts 50% or more of patient encounter in county with inadequate broadband connectivity or EH is located in such a county, as determined by FCC
26 Patient Electronic Access Timely Access Measure does not specify the timeline for posting; the threshold appears in the language of the rule. The rule states that CMS is expanding the timeline for posting to the portal that was required under the proposed rule (24 hours). Now the timeline for posting is: We (CMS) are instead finalizing that information must be included for access within 48 hours for EPs and are retaining the current 36 hours for eligible hospitals and CAHs.
27 Patient Electronic Access Application Programming Interfaces (APIs) API is set of programming protocols Enables access to data through 3rd party application More flexible than portal; can combine data from numerous sources If API provides View, Download and Transmit functionality, then portal not needed separately
28 API Responsibility Application: 3 rd Party s responsibility API: Provider s responsibility
29 API Responsibility Provide list of compatible applications as provided by EHR vendor Provide necessary connection information
30 Patient Electronic Access Patient Portal API* = Electronic Access: EPs: Within 48 hours of availability EHs: Within 36 hours of availability after discharge *Application Programming Interfaces
31 Coordination of Care through Patient Engagement OBJECTIVE 6: Use CEHRT to engage with patients or their authorized representative about the patient s care. Must meet threshold for 2 out of 3 measures and attest to all 3 measures. MEASURE 1: >10% of unique patients or authorized representative either: View, download or transmit health info, OR Use patient-selected API configured to API in provider s CEHRT to access patient info, OR A combination of both view, download or transmit and API 2017 Threshold for Measure 1: >5% of unique patients Measure 2: >25% of unique patients seen by EP or discharged by EH was sent a secure message through CEHRT or a secure message from patient or representative was responded to using a secure message Threshold for Measure 2: >5% of unique patients MEASURE 3: For >5% of unique patients, either patient-generated health data or data from a non-clinical setting is incorporated into the EHR. EXCLUSIONS: EP: EP has no office visits during the reporting period EP/EH: EP conducts 50% or more of patient encounter in county with inadequate broadband, as determined by FCC, or hospital is located in such a county.
32 Coordination of Care through Patient Engagement Measure 1: View/Download/Transmit/API Although EP and EH are not required to use the API as part of the threshold for Patient Engagement Measure 1, under Patient Electronic Access (Objective 5), need to have the functionality enabled and information pushing to the API as well as to the portal (if portal is also being used to meet the VDT functionality). In 2018 it becomes 10% To meet Stage 3 in 2017, the measure is >5% of patients view/download/transmit or use API.
33 Coordination of Care through Patient Engagement Measure 2: Secure Messaging Moves from patient generated to provider generated . Can count patient generated s but only when provider responds. Not required to respond to all s, but can only count if EP/EH does respond. Includes s to other care team members when the patient is engaged in the message and has the ability to be an active participant in the conversation. In 2018 this becomes 25% To meet Stage 3 in 2017, the measure is >5% of patients sent an .
34 Coordination of Care through Patient Engagement Measure 3: Patient-Generated Health Data/Data from a Non-Clinical Setting A. Data Generated from a Non-Clinical Setting Definition: Data generated in a setting by a provider who is not an EP or EH and where provider does not have access to a shared CEHRT system. Examples of types of providers: Nutritionists, PTs, OTs, psychologists, home health care providers, behavioral health providers or patient. Types of data can include social service data, patient generated data, medical device data, home health monitoring data, and fitness monitoring data. Technology used to monitor chronic care is specifically mentioned.
35 Coordination of Care through Patient Engagement Measure 3: Patient-Generated Health Data/Data from a Non-Clinical Setting B. Patient-Generated Health Data (Subset of Non-Clinical Data) Definition: Patient self-monitoring of his/her health, either on own or under the direction of a provider. Can include information that patient provides remotely as opposed that gathered in the office or hospital setting (e.g., patient sends family health history or advanced directive via mail or ) Information must be incorporated into patient record to count, but does not have to be discrete data as long as it is attached to patient record in some manner (e.g., as attachment, a link, or a text reference). If it can be easily incorporated into an existing data field in CEHRT (e.g., demographic info, family history) provider may do so.
36 Health Information Exchange OBJECTIVE 7: EP/EH must (1) provide a summary of care record when transitioning or referring the patient to another setting of care; (2) retrieve a summary of care record upon the first patient encounter with a new patient; and (3) incorporate summary of care information from other providers into their EHR. Must meet threshold for 2 out of 3 measures and attest to all 3 measures.
37 Health Information Exchange Common Clinical Data Set (CCDS) All information pertaining to Health Information Exchange is now termed part of the Common Clinical Data Set rather than Common MU Data Set. Required elements for CCDS are: Demographics Current problem list (can include elements of historical problem list if desired; not required) Current medication list Current medication allergy list All other fields may be left blank if information not available and still meet the summary of care requirements. Addition of new data items including unique device identifier (UDI) for implantable devices. Inclusion of data for CCDS is determined by clinical relevancy, as decided by the provider in conjunction with IT vendor.
38 Health Information Exchange Must Meet 2 Out of 3 50% Data Out by: 1) DIRECT 2) Community Health Record Data In by: 1) Receipt of CCD via DIRECT 2) Query of Community Health Record Must incorporate pertinent results into patient s record 40% Exclusion: < 100 referrals or transitions 80% Clinical Information Reconciliation for: 1) Meds 2) Med Allergies 3) Problems
39 Health Information Exchange Measure 1 Electronic Exchange of Summary of Care OBJECTIVE 7: EP/EH must (1) provide a summary of care record when transitioning or referring the patient to another setting of care; (2) retrieve a summary of care record upon the first patient encounter with a new patient; and (3) incorporate summary of care information from other providers into their EHR. Must meet threshold for 2 out of 3 measures and attest to all 3 measures. MEASURE 1: >50% of transitions of care and referrals, the provider that transitions or refers patient to another setting of care: (1) Creates a summary of care record using CEHRT; AND (2) Electronically exchanges the summary of care record. MEASURE 1 EXCLUSIONS: EP: EP who has < 100 transitions of care or referrals during the reporting period EP/EH: EP conducts 50% or more of patient encounter in county with inadequate broadband, as determined by FCC, or hospital is located in such a county.
40 Health Information Exchange Measure 1 Electronic Exchange of Summary of Care Originally limited to EPs or EHs that (1) did not share a tax ID # and (2) did not share access to CEHRT. Now electronic exchange has been broadened to include any providers that have, at a minimum, different billing identities, e.g., different NPIs or CCN #s. Some examples that would be included under this policy would be one EP sending to another EP in the same group practice, an eligible hospital sending to an EP in an ambulatory setting which shares the hospital s EHR, or a provider sending to a non-ep practitioner who may have shared access to the EHR but whose patient encounters are not included under the referring EPs supervision. Examples that would be excluded are: EP referring patient to another setting but the same EP is the provider Referral from one clinical setting to another within the same hospital EP sending to a non-ep who is under the direct supervision of the EP Can tailor the CCDS to send only information deemed clinically relevant must maintain all data in CEHRT in case requested in the future.
41 Health Information Exchange Measure 2 Incorporation of Summary of Care in Patient Record OBJECTIVE 7: EP/EH must (1) provide a summary of care record when transitioning or referring the patient to another setting of care; (2) retrieve a summary of care record upon the first patient encounter with a new patient; and (3) incorporate summary of care information from other providers into their EHR. Must meet threshold for 2 out of 3 measures and attest to all 3 measures. MEASURE 2: For >40% of transitions or referrals received & provider has never before encountered patient, incorporates into EHR an electronic summary of care document from another source. If provider did not receive a CCDA for the patient then queries at least one external source via HIE functionality. MEASURE 2 EXCLUSION: EP/EH total transitions received in which provider has never before encountered patient is < 100 during reporting period.
42 Health Information Exchange Measure 2 Incorporation of Summary of Care in Patient Record Patient must be a new patient or one that has transitioned back into the practice. No proposed limit on when a patient is considered a new patient. Can also query the Community Health Record (CHR) via the HIE for patient summary of care. If no record found, then do not count in denominator. Summary of care document must be consumed as discrete data elements by the CEHRT system to count, not just viewed.
43 Health Information Exchange Measure 3 Clinical Information Reconciliation OBJECTIVE 7: EP/EH must (1) provide a summary of care record when transitioning or referring the patient to another setting of care; (2) retrieve a summary of care record upon the first patient encounter with a new patient; and (3) incorporate summary of care information from other providers into their EHR. Must meet threshold for 2 out of 3 measures and attest to all 3 measures. MEASURE 3: >80% of transitions or referrals received & provider has never before encountered patient the provider performs a clinical information reconciliation for the following 3 clinical information sets: (1) Medication review of patient s medication including name, dosage, frequency, and route of each medication. (2) Medication allergy review of patient s known allergic medications. (3) Current problem list review of the patient s current & active diagnoses. MEASURE 3 EXCLUSION: EP/EH total transitions received in which provider has never before encountered patient is < 100 during reporting period.
44 Health Information Exchange Measure 3 Clinical Information Reconciliation Clinical Information Reconciliation is defined as the process of creating the most accurate patient-specific information in one or more categories. Must include reconciliation for the following 3 areas: 1. Medication 2. Medication allergy 3. Current problem list
45 Health Information Exchange Information can be limited in C-CDA to information that is clinically relevant, specifically: Lab results that best represent the patient status upon admission, any abnormal results, and patient status upon discharge. Provider s CEHRT must have ability to send all lab results If receiving provider or patient requests it, all lab results must be sent.
46 Public Health/Clinical Data Registry Reporting OBJECTIVE 8: EP/EH is in active engagement with a public health agency or clinical data registry to submit electronic public health data in a meaningful way using certified EHR technology, except where prohibited and in accordance with applicable law and practice.
47 Public Health/Clinical Data Registry Reporting Proposed Single Objective: The EP, EH or CAH is in active engagement with a Public Health Agency (PHA) or Clinical Data Registry (CDR) to submit electronic public health data in a meaningful way using certified EHR technology, except where prohibited, and in accordance with applicable law and practice. Active Engagement: Includes 3 options (1) Completed Registration of Intent to Submit Data; (2) Testing and Validation; or (3) Production. Clinical data registries must support registration of intent process. Proposed Centralized Repository: CMS planning a repository of national, state and local PHA and CDR readiness. Public health agencies and clinical data registries MUST give 6 month s notice as to whether they will be ready to accept data at the beginning of the reporting period.
48 Public Health Measures Options Eligible Provider(EP): Must select 2 public health/registry options Eligible Hospital(EH/CAH): Must select 4public health/registry options # Measure Description Maximum Time Measure counts for EP Maximum Time Measure counts for EH 1 Immunization Registry Reporting Syndromic Surveillance Reporting 1 (N/A except for urgent care settings) 3 Case Reporting Public Health Registry Reporting Includes CDC or Cancer Registry (EP Only) Clinical Data Registry Reporting Electronic Lab Reporting (Infectious Disease) N/A 1
49 Public Health Exclusions* EHs and EPs cannot take an exclusion unless available measures are less than the number required (i.e., must show that provider is excluded from all other measures). # Measure Description EH/CAH Exclusions EP Exclusions 1 Immunization Registry Reporting 2 Syndromic Surveillance Reporting Does not administer immunizations during period Does not have ED or Urgent Care Does not administer immunizations during period Not eligible to report except those in urgent care settings 3 Case Reporting Unknown Unknown 4 Public Health Registry Reporting Includes CDC or Cancer Registry (EP Only) 5 Clinical Data Registry Reporting 6 Electronic Lab Reporting (Infectious Disease) Does not diagnose or treat disease or condition associated with registry Does not diagnose or treat disease or condition associated with registry Does not conduct on-site testing for any of the 13 reportable conditions Does not diagnose or treat disease or condition associated with registry Does not diagnose or treat disease or condition associated with registry N/A *The official ODH policy on exclusions can be found at
50 Public Health Registration of Intent Providers that intend to meet MU public health objectives/measures must register their intent to do so with ODH. Registration of intent must occur by the 60th day of the provider s EHR reporting period at: Providers should register as entities, not individually unless multiple data feeds are necessary. ODH does not require EPs/EHs to re-register intent if they have registered in a prior reporting period.
51 Clinical Quality Reporting (EPs) CQM reporting is finalized for 2015 and is the same as 2014 reporting: EPs need to report 9 CQMs across 3 domains Type of Reporting: In 2015, can attest to a 90 day reporting period for CQMs In 2016, can attest or submit ecqms for a 1 year reporting period In 2017, can either attest or submit ecqms but must cover 1 full year of CQMs even if attesting for Stage 3 for 90 days In 2018, must submit ecqms
52 Clinical Quality Reporting (EHs) CQM reporting is finalized for 2015 and is the same as 2014 reporting. If submitting electronically, submit through QualityNet Portal Type of Reporting: A. IPPS EHs Participating in Hospital IQR Program: In 2015, can attest to a 90 day reporting period for CQMs - 16 measures In 2016, must submit 1 quarter of ecqms for either Q3 or Q4-4 measures - Use 2014 certified measures - If can t report, can file for Extraordinary Circumstances Exemption (ECE) e.g., infrastructure challenges, vendor issues
53 Clinical Quality Reporting (EHs) cont CQM reporting is finalized for 2015 and is the same as 2014 reporting. If submitting electronically, submit through QualityNet Portal Type of Reporting: A. IPPS EHs Participating in Hospital IQR Program (cont): In 2017, may attest or submit ecqms - Full calendar year, even if attesting for Stage 3 for 90 days (except for new providers) Annual update for CQM measures; either 2014 or 2015 Edition CEHRT - Report by quarter through QualityNet portal In 2018, must submit ecqms 2017 annual update for CQMs; 2015 Edition CEHRT Medicaid has the option of continuing attestation for Medicaid hospitals (i.e., Children s Hospitals) for all reporting periods.
54 Clinical Quality Reporting (CAHs) CQM reporting is finalized for 2015 and is the same as 2014 reporting. If submitting electronically, submit through QualityNet Portal Type of Reporting: B. CAHs: In 2015, can attest to a 90 day reporting period for CQMs - 16 measures In 2016, can attest to a one year reporting period for CQMs - If attest, then 16 measures with aggregate data - If ecqm, then 4 measures with patient-specific (QRDA-I) data In 2017, can either attest or submit ecqms In 2018, must submit ecqms
55 Customized support for provider & hospital Meaningful Use. Meaningful Use mock audits & audit response support Resources to assist PQRS and GPRO reporting. Guidance on Chronic Care Management (CCM) and Transitional Care Management (TCM). Ohio-specific information on Public Health Reporting from the Ohio Department of Health and attestation updates from the Ohio Department of Medicaid.
56 Cathy Costello Scott Mash While visiting our website don t forget to sign up for our newsletter!
Centers for Medicare and Medicaid Services Final Rule - Stage 3 Meaningful Use Criteria Objectives and Measures Summary October 22, 2015 Version 1.2 Provided by www.clinicalarchitecture.com Contents Overview...
Objective # & Name 1-Protect Electronic Health Information 2-Electronic Prescribing (erx) Objective Description Measures Exclusions Protect electronic protected health information (ephi) created or maintained
Meaningful Use: Stage 3 Rule Chart Objectives: Objective 1-Protect Patient Health Information: Protect electronic protected health information (ephi) created or maintained by the CEHRT through the implementation
Meaningful Use Updates Stage 2 and 3 Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015 Stage 2 Requirements 2015 EPs beyond 1st year of MU must report on a full year of data EPs in 1 st year
Protect Patient Health Information Protect electronic protected health information (ephi) created or maintained by the certified EHR technology through the implementation of appropriate technical, administrative
Stage 3 Meaningful Use In October 2015, CMS released the Medicare and Medicaid Programs: Electronic Health Record Incentive Program Stage 3 and Modifications to Meaningful Use in 2015 through 2017 final
Meaningful Use in 2015 and Beyond Changes for Stage 2 Jennifer Boaz Transformation Support Specialist Proprietary 1 Definitions AIU = Adopt, Implement or Upgrade EP = Eligible Professional API = Application
On April 10, 2015, CMS released the proposed rule for Meaningful Use in 2015 through 2017. This document summarizes the key points from that proposal. - Reporting Period Length - 2015: 90 consecutive days
Objective # & Name Objective Description Measures Exclusions 1-Protect Patient None Health Information 2-Clinical Decision Support 3-Computerized Provider Order Entry (CPOE) Protect electronic health information
EHR Incentive Programs: 2015 through 2017 (Modified Stage 2) Overview CMS recently released a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals, and critical access
Modified Stage 2 Meaningful Use s 2015-2017 Objective 1: Protect Electronic Health Information NONE Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1)
Medicaid EHR Incentive Program Modified Stage 2: through 2017 November 10, Kim Davis-Allen, Outreach Coordinator Kim.email@example.com November 10, 1 Key Concepts for Modified Stage 2 Restructured
Meaningful Use Stage 3 Rule: What it Means for Hospitals, Physicians & Health IT Developers Vernessa T. Pollard and Nicole Liffrig Molife April 2015 With the publication of the Stage 3 Meaningful Use Rule
EHR Incentive Programs for Eligible Professionals: What You Need to Know for 2015 Tipsheet CMS recently published a final rule that specifies criteria that eligible professionals (EPs), eligible hospitals,
1 EP EH CPOE: Use CPOE for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per State, local and professional
Image Research, LLC Christopher B. Sullivan, Ph.D. 2901 Quail Rise Court, Tallahassee, FL 32309 Summary of the Final Rule for Meaningful Use for 2015 and 2016 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers
Modified Stage Two Meaningful Use 2015-2017 with Final Rule Quick Reference Guide To qualify for Stage 1 or 2, a provider must meet: 10 objectives, Including 2 consolidated public health measures Reporting
Modified Stage 2 Final Rule 2015-2017 Illinois Health Information Technology Regional Extension Center (ILHITREC) SUPPORT PROVIDED BY ILHITREC: The Illinois Health Information Technology Regional Extension
2015 User Conference Meaningful Use Overview (State of Affairs) April 23, 2015 Presented by: Peter Minio Product Manager, Pediatric and Primary Care Solutions Co-Presenter: Cindy Malek Training Specialist
Click to edit Master title style Modified Stage 2 Meaningful Use 2015-2017 Bruce Maki, MA M-CEITA / Altarum Institute Regulatory & Incentive Program Analyst 12/14/2015 1 1 Agenda 1. Overview of M-CEITA
Meaningful Use Updates HIT Summit September 19, 2015 Meaningful Use Updates Nadine Owen, BS,CHTS-IS, CHTS-IM Health IT Analyst Hawaii Health Information Exchange No other relevant financial disclosures.
MEDICFUSION / HERFERT MEANINGFUL USE STAGE 1 and 2 ATTESTATION GUIDE 2015 The following document is intended to aid in preparation for gathering necessary information to attest in early 2016. All Medicfusion
MEANINGFUL USE STAGE 2 Summary of Proposed Rule (EP) The Meaningful Use Stage 2 Notice of Proposed Rule Making (NPRM) has been released and entered a 60-day comment period (March 7-May 6, 2012). HealthInsight
MEETING MEANINGFUL USE IN MICROMD -STAGE TWO- Presented by: Anna Mrvelj EMR Training Specialist 1 Proposed Rule On April 15, 2015 CMS Issued a new proposal rule for the Medicare and Medicaid EHR Incentive
This checklist provides a look into Ohio s Medicaid Provider Incentive Program (MPIP) system for eligible professionals and may be used as a guide to help eligible professionals gather information that
STAGE 2 MEANINGFUL USE CORE AND MENU MEASURES FOR ELIGIBLE PROFESSIONALS CORE MEASURES must meet all CPOE for Medication, Laboratory and Radiology Orders Objective: Use computerized provider order entry
Meaningful Use Stage 2 Presented by: Sarah Leake, HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 HTS Who We Are Stage 2 MU Overview Learning Objectives 2014 CEHRT Certification
Medicaid EHR Incentive Program Focus on Stage 2 Kim Davis-Allen, Outreach Coordinator Kim.firstname.lastname@example.org Understanding Participation Program Year Program Year January 1 st - December 31st. Year
AQAF Health Information Technology Forum Meaningful Use Stage 2 Clinical Considerations Marla Clinkscales & Mike Bice Alabama Regional Extension Center (ALREC) August 13, 2013 0 Agenda What is Meaningful
Pain Points in Meaningful Use What we ve learned and what to expect Kathy Church, BSN PMP Director of Fiona Clinical Taggart, Operations MIS Audits Meaningful Use Killed it! So you think http://themetapicture.com/the-circle-oflife/?&cuid=1b4168ce22246bc00d5a25231d7a9f81
CMS Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs Final Rule Overview October 8, 2015 Elizabeth S. Holland Center for Clinical Standards and Quality Centers for Medicare & Medicaid
Meaningful Use Stage 2 MU Audits Presented by: Deb Anderson, CPHIMS HTS Consultant HTS, a division of Mountain Pacific Quality Health Foundation 1 CEHRT Certified Electronic Health Record Technology (EHR)
Eligible Hospital and Critical Access Hospital (CAH) Attestation Worksheet for Stage 2 of the Medicare Electronic Health Record (EHR) Incentive Program The Eligible Hospital and CAH Attestation Worksheet
Meaningful Use 2015 and beyond Presented by: Anna Mrvelj EMR Training Specialist 1 Agenda A look at the CMS Website Finding your EMR version Certification Number Proposed Rule by the Centers for Medicare
Overview and Key Takeaways from the Proposed Rule on Meaningful Use Stage 3 April 2015 Impact Advisors LLC 400 E. Diehl Road Suite 190 Naperville IL 60563 1-800- 680-7570 Impact- Advisors.com Background
Meaningful Use Modification Rules for 2015-2017 Oct. 26, 2015 Author: Jennifer Swinnich, Associate Director, PAMED Practice Support The following is a summary of the Meaningful Use Modifications for 2015-2017.
MEANINGFUL USE STAGE 2 2015 FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY STAGE 2 REQUIREMENTS EPs must meet or qualify for an exclusion to 17 core objectives EPs must meet 3 of the 6 menu measures.
Meaningful Use Dashboard Calculation Guide Learn how to use Practice Fusion s Meaningful Use Dashboard to help you achieve Meaningful Use. For more information, visit the Meaningful Use Center. General
Meaningful Use Stage 2 Administrator Training 1 During the call please mute your line to reduce background noise. 2 Agenda Review of the EHR Incentive Programs for Stage 2 Meaningful Use Measures and Corresponding
Stage 1 vs. Comparison for Eligible Professionals CORE OBJECTIVES (17 Total) Stage 1 Objective Stage 1 Measure Objective Measure Use CPOE for Medication orders directly entered by any licensed healthcare
CORE OBJECTIVES (16 total) Stage 1 vs. Stage 2 Comparison Table for Eligible Hospitals and CAHs Last Updated: August, 2012 Stage 1 Objective Use CPOE for medication orders directly entered by any licensed
EHR Incentive Program Stage 2 Objectives Summary CORE OBJECTIVES (You must meet all objectives unless exclusion applies.) TARGETING CANCER CARE Objective Objective Description Measure/Attestation Requirement
MEDICAL ASSISTANCE STAGE 2 SUMMARY OVERVIEW On September 4, 2012, CMS published a final rule that specifies the Stage 2 Meaningful Use criteria that eligible professionals (EPs), eligible hospitals (EHs)
Medicaid EHR Incentive Program Dentists as Eligible Professionals Kim Davis-Allen, Outreach Coordinator Kim.email@example.com Considerations Must begin participation by Program Year 2016 Not required
Summary of Key Provisions: CMS EHR Incentive Program Modifications to Meaningful Use in 2015 through 2017 (Final Rule) Structure of the Rules: CMS originally published three separate Proposed Rules: Health
EHR Incentive Programs A program administered by the Centers for Medicare & Medicaid Services (CMS) Eligible Professional s Guide to STAGE 2 of the EHR Incentive Programs September 2013 TABLE OF CONTENTS...
Meaningful Use Stage 1 Core Objectives Must Meet all 13 Objectives 1. CPOE for Medication Orders 2. Drug Interaction Checks 3. Up-To-Date Problem List 4. E-Prescribing (erx) 5. Active Medication List 6.
Ready or Not, Here it Comes: Meaningful Use Audits, Appeals and Stage 3 OHIO HOSPITAL ASSOCIATION ANNUAL MEETING JUNE 8, 2015 Catherine C. Costello, JD Director, CliniSyncPLUS Ohio Health Information Partnership
Stage 2 Final Rule Overview: Updates to Stage 1 and New Stage 2 Requirements The Centers for Medicare and Medicaid Services (CMS) issued the Stage 2 Final Rule on September 4, 2012. The Stage 2 Final Rule
PROGRAMMATIC CHANGES: SUPPORT full-year reporting (vs. 90 day reporting periods) to make benefits of online access available to patients and families 365 days a year, and also to transform clinical practices
Medicaid Meaningful Use: 2015 Final Rule and Stage 3 Stephanie Rose, HCNNY Amy Tammam, CHCANYS November 2015 Agenda 1. Medicaid Meaningful Use Program Overview 2. Overview of Meaningful Use Modifications
EHR Incentive Program Focus on Stage One Meaningful Use Kim Davis-Allen, Outreach Coordinator Kim.firstname.lastname@example.org October 16, 2014 Checklist Participation Explanation Program Updates Stage One
Research Primer: EHR Stage 3 Meaningful Use Requirements TARA O'NEILL OCTOBER 28, 2015 Introduction On October 6, 2015, the Centers for Medicare and Medicaid (CMS) published its final rule on Stage 3 of
MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY On August 24, the Centers for Medicare & Medicaid Services (CMS) posted the much anticipated final rule for Stage
Meaningful Use: Stage 1 and 2 Hospitals (EH) and Providers (EP) Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality Meaningful Use Stage 1 Focuses on Functional & Interoperability
CMS-0044-P 156 TABLE 4: STAGE 2 MEANINGFUL USE OBJECTIVES AND ASSOCIATED MEASURES SORTED BY CORE AND MENU SET Improving quality, safety, efficiency, and reducing health disparities Use computerized provider
EHR/Meaningful Use 2015-2017 The requirements for Meaningful Use attestation have changed due to the recently released Medicare and Medicaid Programs: Electronic Health Record Incentive Program Stage 3
This chart reflects the applicability and potential achievability of MU requirements for an anesthesiologist who: - Provides surgical anesthesia and writes fewer than 100 outpatient prescriptions per year
Michigan Medicaid EHR Incentive Program Update Jason Werner - MDCH Program Timeline Meaningful Use Timeline Meaningful Use Stages st year 0 0 03 04 05 06 07 08 09 00 0 0 AIU $,50 3 TBD TBD TBD TBD 0 AIU
CMS & ONC Final Rules: 2015 & Beyond Today s Presenters: Al Wroblewski, Client Services Relationship Manager Joe Kynoch, Project Manager Disclaimer This presentation was current at the time it was presented,
Meaningful Use and Lab Related Requirements ONC State HIE / NILA Workgroup August 20, 2013 What is an EHR? Electronic Health Record Information system used by healthcare providers to store and manage patient
Product Mappings to the ARRA/HITECH Stage 1 Requirements for Eligible Providers Number CORE SET (These objectives are to be achieved by all eligible professionals in order to qualify for incentive payments.)
Meaningful Use Madness: Stage 3 Overview APRIL 08, 2015 Agenda Health IT Updates EHR Meaningful Use Incentive Program Rulemaking CMS Policy NPRM Stage 3 ONC Technical NPRM 2015 Edition CEHRT Proposed structural
Improving quality and safety Work Product of the HITPC Meaningful Use Workgroup Meaningful Use Stage 3 Recommendations Clinical Decision Support Eligible Professionals (EPs)/Eligible Hospitals (EH) Core
Making Sense of Meaningful Use: Stage 2 1 Who are we? Purdue Healthcare Advisors (PHA)*, a business unit of Purdue University, specializes in affordable assistance to organizations that share our passion
294 TABLE B5: STAGE 2 OBJECTIVES AND MEASURES CORE SET Improving quality, safety, efficiency, and reducing health disparities Use computerized provider order entry (CPOE) for medication, laboratory and
Meaningful Use Objectives The purpose of the electronic health records (EHR) incentive program is not so much the adoption of health information technology (HIT), but rather how HIT can further the goals
Who are we? Purdue Healthcare Advisors (PHA)*, a business unit of Purdue University, specializes in affordable assistance to organizations that share our passion for healthcare transformation. We bring
Meaningful Use and Quality Reporting: What s here now, what s changing, and what s coming next? Where to go for Help, Handouts, and Future Updates Disclosures: Dr. Henry is affiliated with www.ehrguru.net
EMR Name/ Model EMR Vendor Cerner PowerChart Ambulatory (PowerWorks ASP) Cerner Corporation Core Set of Measures 1 Use CPOE for medication orders directly entered by any licensed healthcare professional
Presented by Terri Gonzalez Director of Practice Improvement North Carolina Medical Society Meaningful Use is using certified EHR technology to: Improve quality, safety, efficiency, and reduce errors Engage
Contact Information: West Texas Health Information Technology Regional Extension Center 3601 4 th Street MS 6232 Lubbock, Texas 79424 806-743-1338 http://www.wtxhitrec.org/ Grant award - $6.6m Total number
November 8, 2012 Practice Group: Health Care Stage 2 of Meaningful Use: Ten Points of Interest By Patricia C. Shea On September 4, 2012, the Department of Health and Human Services, Centers for Medicare
Improving quality and safety Clinical Decision Support Eligible Professionals (EPs)/Eligible Hospitals (EH) Core Objective: Use clinical decision support to improve performance on highpriority health conditions
Meaningful Use 2014: Stage 2 MU Overview Scott A. Jens, OD, FAAO October 16, 2013 Overview General Overview of Stage 2 MU in 2014 Core Objectives for Stage 2 Menu Objectives for Stage 2 Complete summary
MICROMD EMR VERSION 9.0 2014 OBJECTIVE MEASURE CALCULATIONS TABLE OF CONTENTS PREFACE Welcome to MicroMD EMR... i How This Guide is Organized... i Understanding Typographical Conventions... i Cross-References...
Understanding Meaningful Use Daniel Chipping, MBA, MHA Project Manager, Health Information Technology Renee G. Sussman, RN, MSN, MA Director, Health Information Technology Objectives Meaningful Use (MU)
Meaningful Use: It s Not Too Late For 2015! Jeffrey D. Lehrman, DPM, FACFAS, FASPS, FAPWH APMA Coding Committee Expert Panelist, Codingline.com Fellow, American Academy of Podiatric Practice Management
Meaningful Use Stage 2: Summary of Proposed Rule for Eligible Professionals (EPs) Wyatt Packer HIT Regional Extension Center (REC) HealthInsight Notice of Proposed Rule Making (NPRM) Stage 2 proposed rule
Stage 2 Overview Tipsheet Last Updated: August, 2012 Overview CMS recently published a final rule that specifies the Stage 2 criteria that eligible professionals (EPs), eligible hospitals, and critical
Overview of MU Stage 2 Joel White, Health IT Now 1 Agenda 1. Introduction 2. Context 3. Adoption Rates of HIT 4. Overview of Stage 2 Rules 5. Overview of Issues 6. Trend in Standards: Recommendations v.
How to Achieve Meaningful Use with ICANotes Meaningful use involves using an EHR in a way that the government has defined as meaningful to collect incentive payments. but do not participate. Note: If you